AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29
FETAL STRIATAL ALLOGRAFTS REVERSE COGNITIVE DEFICITS IN A PRIMATE MODEL OF HUNTINGTON-DISEASE
Authors: PALFI S CONDE F RICHE D BROUILLET E DAUTRY C MITTOUX V CHIBOIS A PESCHANSKI M HANTRAYE P
Citation: S. Palfi et al., FETAL STRIATAL ALLOGRAFTS REVERSE COGNITIVE DEFICITS IN A PRIMATE MODEL OF HUNTINGTON-DISEASE, Nature medicine, 4(8), 1998, pp. 963-966
MODELING DOPAMINE SYSTEM DYSFUNCTION IN EXPERIMENTAL-ANIMALS
Authors: HANTRAYE P
Citation: P. Hantraye, MODELING DOPAMINE SYSTEM DYSFUNCTION IN EXPERIMENTAL-ANIMALS, Nuclear medicine and biology, 25(8), 1998, pp. 721-728
COGNITIVE RECOVERY FOLLOWING NEURAL ALLOGRAFTS IN A PRIMATE MODEL OF HUNTINGTONS-DISEASE
Authors: PALFI S HANTRAYE P PESCHANSKI M
Citation: S. Palfi et al., COGNITIVE RECOVERY FOLLOWING NEURAL ALLOGRAFTS IN A PRIMATE MODEL OF HUNTINGTONS-DISEASE, MS. Medecine sciences, 14(8-9), 1998, pp. 997-999
PARTIAL INHIBITION OF BRAIN SUCCINATE-DEHYDROGENASE BY 3-NITROPROPIONIC ACID IS SUFFICIENT TO INITIATE STRIATAL DEGENERATION IN RAT
Authors: BROUILLET E GUYOT MC MITTOUX V ALTAIRAC S CONDE F PALFI S HANTRAYE P
Citation: E. Brouillet et al., PARTIAL INHIBITION OF BRAIN SUCCINATE-DEHYDROGENASE BY 3-NITROPROPIONIC ACID IS SUFFICIENT TO INITIATE STRIATAL DEGENERATION IN RAT, Journal of neurochemistry, 70(2), 1998, pp. 794-805
MRI-STEREOTACTICAL APPROACH FOR NEURAL GRAFTING IN BASAL GANGLIA DISORDERS
Authors: PALFI S NGUYEN JP BRUGIERES P LEGUERINEL C HANTRAYE P REMY P ROSTAING S DEFER GL CESARO P KERAVEL Y PESCHANSKI M
Citation: S. Palfi et al., MRI-STEREOTACTICAL APPROACH FOR NEURAL GRAFTING IN BASAL GANGLIA DISORDERS, Experimental neurology, 150(2), 1998, pp. 272-281
PRESYNAPTIC DOPAMINERGIC FUNCTION IN THE STRIATUM OF SCHIZOPHRENIC-PATIENTS
Authors: DAOCASTELLANA MH PAILLEREMARTINOT ML HANTRAYE P ATTARLEVY D REMY P CROUZEL C ARTIGES E FELINE A SYROTA A MARTINOT JL
Citation: Mh. Daocastellana et al., PRESYNAPTIC DOPAMINERGIC FUNCTION IN THE STRIATUM OF SCHIZOPHRENIC-PATIENTS, Schizophrenia research, 23(2), 1997, pp. 167-174
RILUZOLE PROTECTS FROM MOTOR DEFICITS AND STRIATAL DEGENERATION PRODUCED BY SYSTEMIC 3-NITROPROPIONIC ACID INTOXICATION IN RATS
Authors: GUYOT MC PALFI S STUTZMANN JM MAZIERE M HANTRAYE P BROUILLET E
Citation: Mc. Guyot et al., RILUZOLE PROTECTS FROM MOTOR DEFICITS AND STRIATAL DEGENERATION PRODUCED BY SYSTEMIC 3-NITROPROPIONIC ACID INTOXICATION IN RATS, Neuroscience, 81(1), 1997, pp. 141-149
QUANTIFIABLE BRADYKINESIA, GAIT ABNORMALITIES AND HUNTINGTONS-DISEASE-LIKE STRIATAL LESIONS IN RATS CHRONICALLY TREATED WITH 3-NITROPROPIONIC ACID
Authors: GUYOT MC HANTRAYE P DOLAN R PALFI SM MAZIERE M BROUILLET E
Citation: Mc. Guyot et al., QUANTIFIABLE BRADYKINESIA, GAIT ABNORMALITIES AND HUNTINGTONS-DISEASE-LIKE STRIATAL LESIONS IN RATS CHRONICALLY TREATED WITH 3-NITROPROPIONIC ACID, Neuroscience, 79(1), 1997, pp. 45-56
RELATIONSHIPS BETWEEN MOTOR-PERFORMANCE AND [18]-FLUORODOPA UPTAKE MEASURED WITH PET IN PARKINSONS-DISEASE
Authors: REMY P DUPELPOTTIER C VIDAILHET M HANTRAYE P CESARO P SAMSON Y
Citation: P. Remy et al., RELATIONSHIPS BETWEEN MOTOR-PERFORMANCE AND [18]-FLUORODOPA UPTAKE MEASURED WITH PET IN PARKINSONS-DISEASE, Neurology, 48(3), 1997, pp. 4090-4090
RILUZOLE REDUCES INCIDENCE OF ABNORMAL MOVEMENTS BUT NOT STRIATAL CELL-DEATH IN A PRIMATE MODEL OF PROGRESSIVE STRIATAL DEGENERATION
Authors: PALFI S RICHE D BROUILLET E GUYOT MC MARY V WAHL F PESCHANSKI M STUTZMANN JM HANTRAYE P
Citation: S. Palfi et al., RILUZOLE REDUCES INCIDENCE OF ABNORMAL MOVEMENTS BUT NOT STRIATAL CELL-DEATH IN A PRIMATE MODEL OF PROGRESSIVE STRIATAL DEGENERATION, Experimental neurology, 146(1), 1997, pp. 135-141
INHIBITION OF NEURONAL NITRIC-OXIDE SYNTHASE PREVENTS MPTP-INDUCED PARKINSONISM IN BABOONS
Authors: HANTRAYE P BROUILLET E FERRANTE R PALFI S DOLAN R MATTHEWS RT BEAL MF
Citation: P. Hantraye et al., INHIBITION OF NEURONAL NITRIC-OXIDE SYNTHASE PREVENTS MPTP-INDUCED PARKINSONISM IN BABOONS, Nature medicine, 2(9), 1996, pp. 1017-1021
WHAT IS NEEDED VERSUS WHAT WOULD-BE INTERESTING TO KNOW BEFORE UNDERTAKING NEURAL TRANSPLANTATION IN PATIENTS WITH HUNTINGTONS-DISEASE
Authors: PESCHANSKI M CESARO P HANTRAYE P
Citation: M. Peschanski et al., WHAT IS NEEDED VERSUS WHAT WOULD-BE INTERESTING TO KNOW BEFORE UNDERTAKING NEURAL TRANSPLANTATION IN PATIENTS WITH HUNTINGTONS-DISEASE, Neuroscience, 71(3), 1996, pp. 899-900
CHRONIC 3-NITROPROPIONIC ACID TREATMENT IN BABOONS REPLICATES THE COGNITIVE AND MOTOR DEFICITS OF HUNTINGTONS-DISEASE
Authors: PALFI SP FERRANTE RJ BROUILLET E BEAL MF DOLAN R GUYOT MC PESCHANSKI M HANTRAYE P
Citation: Sp. Palfi et al., CHRONIC 3-NITROPROPIONIC ACID TREATMENT IN BABOONS REPLICATES THE COGNITIVE AND MOTOR DEFICITS OF HUNTINGTONS-DISEASE, The Journal of neuroscience, 16(9), 1996, pp. 3019-3025
ONTOGENY OF HUMAN STRIATAL DARPP-32 NEURONS IN FETUSES AND FOLLOWING XENOGRAFTING TO THE ADULT-RAT BRAIN
Authors: NAIMI S JENY R HANTRAYE P PESCHANSKI M RICHE D
Citation: S. Naimi et al., ONTOGENY OF HUMAN STRIATAL DARPP-32 NEURONS IN FETUSES AND FOLLOWING XENOGRAFTING TO THE ADULT-RAT BRAIN, Experimental neurology, 137(1), 1996, pp. 15-25
EFFECTS OF CHRONIC MPTP AND 3-NITROPROPIONIC ACID IN NONHUMAN-PRIMATES
Authors: BROUILLET E HANTRAYE P
Citation: E. Brouillet et P. Hantraye, EFFECTS OF CHRONIC MPTP AND 3-NITROPROPIONIC ACID IN NONHUMAN-PRIMATES, Current opinion in neurology, 8(6), 1995, pp. 469-473
THE NEUROTOXICITY OF 3-NITROPROPIONIC ACI D DEMONSTRATES THAT AN INDIRECT EXCITOTOXIC MECHANISM COULD PLAY A KEY ROLE IN HUNTINGTONS-DISEASE
Authors: BROUILLET E PALDI S HANTRAYE P
Citation: E. Brouillet et al., THE NEUROTOXICITY OF 3-NITROPROPIONIC ACI D DEMONSTRATES THAT AN INDIRECT EXCITOTOXIC MECHANISM COULD PLAY A KEY ROLE IN HUNTINGTONS-DISEASE, MS. Medecine sciences, 11(10), 1995, pp. 1489-1491
CLINICAL CORRELATES OF [F-18]FLUORODOPA UPTAKE IN 5 GRAFTED PARKINSONIAN-PATIENTS
Authors: REMY P SAMSON Y HANTRAYE P FONTAINE A DEFER G MANGIN JF FENELON G GENY C RICOLFI F FROUIN V NGUYEN JP JENY R DEGOS JD PESCHANSKI M CESARO P
Citation: P. Remy et al., CLINICAL CORRELATES OF [F-18]FLUORODOPA UPTAKE IN 5 GRAFTED PARKINSONIAN-PATIENTS, Annals of neurology, 38(4), 1995, pp. 580-588
RATIONALE FOR INTRASTRIATAL GRAFTING OF STRIATAL NEUROBLASTS IN PATIENTS WITH HUNTINGTONS-DISEASE
Authors: PESCHANSKI M CESARO P HANTRAYE P
Citation: M. Peschanski et al., RATIONALE FOR INTRASTRIATAL GRAFTING OF STRIATAL NEUROBLASTS IN PATIENTS WITH HUNTINGTONS-DISEASE, Neuroscience, 68(2), 1995, pp. 273-285
CORRELATIONS BETWEEN [F-18] FLUORODOPA UPTAKE MEASURED BY PET AND MOTOR-PERFORMANCE DEMONSTRATE FUNCTIONAL-EFFECTS OF THE GRAFTS IN PARKINSONIAN-PATIENTS
Authors: REMY P HANTRAYE P FONTAINE A DEFER G FENELON F GENY C NGUYEN JP DEGOS JD PESHANSKI M CESARO P SAMSON Y
Citation: P. Remy et al., CORRELATIONS BETWEEN [F-18] FLUORODOPA UPTAKE MEASURED BY PET AND MOTOR-PERFORMANCE DEMONSTRATE FUNCTIONAL-EFFECTS OF THE GRAFTS IN PARKINSONIAN-PATIENTS, Neurology, 45(4), 1995, pp. 409-409
CHRONIC MITOCHONDRIAL ENERGY IMPAIRMENT PRODUCES SELECTIVE STRIATAL DEGENERATION AND ABNORMAL CHOREIFORM MOVEMENTS IN PRIMATES
Authors: BROUILLET E HANTRAYE P FERRANTE RJ DOLAN R LEROYWILLIG A KOWALL NW BEAL MF
Citation: E. Brouillet et al., CHRONIC MITOCHONDRIAL ENERGY IMPAIRMENT PRODUCES SELECTIVE STRIATAL DEGENERATION AND ABNORMAL CHOREIFORM MOVEMENTS IN PRIMATES, Proceedings of the National Academy of Sciences of the United Statesof America, 92(15), 1995, pp. 7105-7109
DOWN-REGULATION OF AMYLOID PRECURSOR PROTEIN INHIBITS NEURITE OUTGROWTH IN-VITRO
Authors: ALLINQUANT B HANTRAYE P MAILLEUX P MOYA K BOUILLOT C PROCHIANTZ A
Citation: B. Allinquant et al., DOWN-REGULATION OF AMYLOID PRECURSOR PROTEIN INHIBITS NEURITE OUTGROWTH IN-VITRO, The Journal of cell biology, 128(5), 1995, pp. 919-927
TH MESSENGER-RNA OVER-EXPRESSION IN RATS WITH CHRONIC EXCITOTOXIC STRIATAL LESIONS
Authors: HANTRAYE P GUIBERT B BIGUET NF LAVERGNE A LEVIEL V
Citation: P. Hantraye et al., TH MESSENGER-RNA OVER-EXPRESSION IN RATS WITH CHRONIC EXCITOTOXIC STRIATAL LESIONS, NeuroReport, 5(18), 1994, pp. 2621-2624
CHRONIC MPTP TREATMENT REPRODUCES IN BABOONS THE DIFFERENTIAL VULNERABILITY OF MESENCEPHALIC DOPAMINERGIC-NEURONS OBSERVED IN PARKINSONS-DISEASE
Authors: VARASTET M RICHE D MAZIERE M HANTRAYE P
Citation: M. Varastet et al., CHRONIC MPTP TREATMENT REPRODUCES IN BABOONS THE DIFFERENTIAL VULNERABILITY OF MESENCEPHALIC DOPAMINERGIC-NEURONS OBSERVED IN PARKINSONS-DISEASE, Neuroscience, 63(1), 1994, pp. 47-56
FETAL MESENCEPHALIC TRANSPLANTATION IN PARKINSONS-DISEASE (PD) - FOLLOW-UP IN 5 PATIENTS WITH POSITRON EMISSION TOMOGRAPHY (PET) AND [F-18]FLUORODOPA (F-18-DOPA)
Authors: REMY P SAMSON Y HANTRAYE P DEFER G FENELON G BENDRIEM B FROUIN V NGUYEN JP DEGOS JD PESCHANSKI M CESARO P
Citation: P. Remy et al., FETAL MESENCEPHALIC TRANSPLANTATION IN PARKINSONS-DISEASE (PD) - FOLLOW-UP IN 5 PATIENTS WITH POSITRON EMISSION TOMOGRAPHY (PET) AND [F-18]FLUORODOPA (F-18-DOPA), Neurology, 44(4), 1994, pp. 10000281-10000281
3-NITROPROPIONIC ACID PRODUCES SELECTIVE STRIATAL LESIONS
Authors: BEAL F BROUILLET E FERRANTE R KOWALL N HANTRAYE P
Citation: F. Beal et al., 3-NITROPROPIONIC ACID PRODUCES SELECTIVE STRIATAL LESIONS, Journal of neurochemistry, 62, 1994, pp. 190000028-190000028
Risultati: 1-25 | 26-29